XML 47 R25.htm IDEA: XBRL DOCUMENT v3.24.0.1
Sale of Pelican Business and Investment in Primrose Bio (Tables)
 12 Months Ended
Dec. 31, 2023
Discontinued Operations and Disposal Groups [Abstract]  
Schedule of Carrying Amounts of Major Classes of Assets and Liabilities Related to Assets Held for Sale
We determined that the sale of Pelican meets the definition of a deconsolidation of a business. Net assets sold together with allocated goodwill and cash consideration paid were as follows (in thousands):
Property and equipment, net$8,250 
Intangible assets19,895 
Other assets717 
Operating lease right-of-use assets8,693 
Financing lease right-of-use assets20 
Accrued liabilities(630)
Deferred revenue(495)
Long-term operating lease liabilities(8,445)
Other liabilities(74)
Net assets sold27,931 
Allocated goodwill4,132 
Cash consideration paid15,000 
$47,063 
The following table summarizes revenue and expenses of the discontinued operations for the years ended December 31, 2022 and 2021 (in thousands):
Year Ended December 31,
20222021
Revenues:
Royalties$1,289 $— 
Contract revenue25,275 35,589 
Total revenues26,564 35,589 
Operating costs and expenses:
Amortization of intangibles10,847 12,945 
Research and development38,466 36,907 
General and administrative13,383 10,693 
Total operating costs and expenses62,696 60,545 
Loss from operations(36,132)(24,956)
Other income (expense):
Gain from short-term investments— 1,266 
Interest expense— (7)
Other income (expense), net554 (1,210)
Total other expense, net554 49 
Loss before income tax(35,578)(24,907)
Income tax benefit7,436 5,692 
Net loss$(28,142)$(19,215)

The following table summarizes the significant non-cash items, capital expenditures of the discontinued operations, and financing activities that are included in the consolidated statements of cash flows for the years ended December 31, 2022 and 2021 (in thousands):
Year Ended December 31,
20222021
Operating activities:
Change in fair value of contingent consideration$(554)$1,210 
Depreciation and amortization13,218 14,553 
Stock-based compensation expense9,404 9,457 
Investing activities:
Cash paid for acquisition, net of cash acquired
$— $— 
Purchase of property, plant and equipment(5,572)(4,070)
Payments to CVR Holders(960)(720)
Financing activities:
Payments to CVR Holders$(1,545)$(1,050)
Supplemental cash flow disclosures:
Purchases of property, plant and equipment included in accounts payable and accrued expenses$2,310 $1,231 
Schedule of Fair Value of the Consideration
Fair value of the consideration received includes the following (in thousands):
Equity method investment$13,706 
Equity securities32,278 
Derivative assets3,200 
$49,184